M Findlay
Impact in
- Oncology top 5%
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Surgical Treatments
- Cancer Treatment and Pharmacology
- Cancer survivorship and care
-
- Gastric Cancer Management and Outcomes
Papers in
- Oncology 5
- Colorectal Cancer Treatments and Studies 5
- Cancer Treatment and Pharmacology 1
-
- Gastric Cancer Management and Outcomes 3
- Lung Cancer Treatments and Mutations 1
- Co-authors
- David Cunningham (4 shared papers)Andrew Richard Norman (2 shared papers)Tamas Hickish (2 shared papers)Maggie Watson (2 shared papers)J. Howard Scarffe (1 shared paper)Johnathan Joffe (1 shared paper)J. R. Oates (1 shared paper)Craig R. Underhill (1 shared paper)
- Journals
- Journal of Clinical Oncology (3 papers)Lung Cancer (1 paper)Annals of Oncology (1 paper)European Journal of Cancer (1 paper)Value in Health (1 paper)
- Partner nations
- United KingdomNew ZealandSwitzerland
In The Last Decade
M Findlay
8 papers receiving 1.7k citations
M Findlay's Hit Papers
Peers
Comparison fields: 5 of 64
- Oncology 756
- Pulmonary and Respiratory Medicine 665
- Pharmacology 97
- Surgery 165
- Dermatology 31
Countries citing papers authored by M Findlay
This map shows the geographic impact of M Findlay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Findlay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Findlay more than expected).
Fields of papers citing papers by M Findlay
This network shows the impact of papers produced by M Findlay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Findlay. The network helps show where M Findlay may publish in the future.
Co-authors
The 25 scholars most cited alongside M Findlay, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Oral Capecitabine Compared With Intravenous Fluorouracil Plus Leucovorin in Patients With Metastatic Colorectal Cancer: Results of a Large Phase III Study Hit paper breakdown → | 2001 | 875 |
| 2 | Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer. Hit paper breakdown → | 1997 | 731 |
| 3 | 1995 | 73 | |
| 4 | 2002 | 60 | |
| 5 | 1996 | 51 | |
| 6 | 1997 | 14 | |
| 7 | Survival benefit with Xeloda (capecitabine)/docetaxel vs docetaxel: analysis of post-study therapy. | 2001 | 12 |
| 8 | 2000 | 1 | |
| 9 | 1993 | 0 |
About M Findlay
M Findlay is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Radiology, Nuclear Medicine and Imaging and Economics and Econometrics, having authored 9 papers that have together received 1.8k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (5 papers), Gastric Cancer Management and Outcomes (3 papers), Lung Cancer Treatments and Mutations (1 paper), Economic and Financial Impacts of Cancer (1 paper), Cancer Treatment and Pharmacology (1 paper), Medical Imaging Techniques and Applications (1 paper), Genetic factors in colorectal cancer (1 paper) and Health Systems, Economic Evaluations, Quality of Life (1 paper). The work is most often cited by research in Oncology (756 citations), Pulmonary and Respiratory Medicine (665 citations), Pharmacology (97 citations), Surgery (165 citations) and Dermatology (31 citations). M Findlay has collaborated with scholars based in United Kingdom, New Zealand and Switzerland. Frequent co-authors include David Cunningham, Andrew Richard Norman, Tamas Hickish, Maggie Watson, J. Howard Scarffe, Johnathan Joffe, J. R. Oates, Craig R. Underhill, Janine Mansi and Marianne C. Nicolson. Their work appears in journals such as Journal of Clinical Oncology, Lung Cancer, Annals of Oncology, European Journal of Cancer and Value in Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.